NovaBay Pharmaceuticals, Inc. 4
4 · NovaBay Pharmaceuticals, Inc. · Filed Oct 3, 2016
Insider Transaction Report
Form 4
SIECZKAREK MARK M
Director
Transactions
- Exercise of In-Money
Common Stock
2016-09-30$1.91/sh+273,447$522,284→ 988,945 total
Footnotes (1)
- [F1]Shares acquired through the exercise of warrants issued in the May 2016 private placement with China Kington Asset Management